Capricor Therapeutics | CAPR - Assets


Capricor Therapeutics reported $368.74M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Bioline Rx USD 38.8M 2.11M Mar/2026
Capricor Therapeutics USD 368.74M 42.45M Jun/2026
Cipla INR 424.96B 23.32B Mar/2026
Cytokinetics USD 1.92B 651.07M Jun/2026
Geron USD 519.01M 15.11M Jun/2026
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 189.74M 165.69M Mar/2026
J&J USD 201.06B 167M Jun/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Prothena USD 302.58M 47.32M Jun/2026
PTC Therapeutics USD 3.25B 381.37M Jun/2026
Sarepta Therapeutics USD 3.19B 9.58M Jun/2026